As Head of Clinical Development Asia Pacific, Dr. Ross Horsburgh leads an extended management team responsible for all clinical functions across this key growth region, where Quintiles employs more than 11,000 people in 13 countries.
Dr. Horsburgh, who joined Quintiles is 2012, is a New Zealander trained in clinical medicine and neuroscience. He has more than 20 years’ experience in Asia, having been assigned to Beijing in 1993 to set up clinical development and regulatory capabilities in Northeast Asia for two global pharmaceutical companies. During his five years in Beijing, he led some of China’s earliest GCP-compliant trials aimed at global approvals for a Chinese-invented and globally patented anti-malarial drug.
Dr. Horsburgh moved to Singapore in 1998 and over the next 14 years held leadership roles with three biopharmaceutical companies (including ASLAN Pharmaceuticals, a Singapore-based biotech he co-founded in 2010) and a mid-size global CRO, building and managing teams responsible for Asia-Pacific clinical development; medical and regulatory affairs; business development and licensing; and market access.
His broad experience in Asia Pacific involving projects in all of the major therapeutic areas, plus his accomplishments in establishing mutually beneficial alliances between local and global organizations, gives him a unique perspective on the current state of the biopharmaceutical industry in the region and its future prospects and challenges.